Artificial Intelligence

A $2,500 scholarship for a promising Howard University student shines a light on corporate efforts to close the persistent diversity gap in science.

As financial firms demand tangible AI results, Wall Street Prep's new Head of AI aims to embed intelligence directly into core banking and investment workflows.

As global landmarks glow red for National Nurses Week, the celebration highlights a profession grappling with severe staffing shortages and systemic burnout.

From KISS to Cash, legendary instruments are up for grabs in a booming memorabilia market where guitars become multi-million dollar assets.

AI fintech Corgi unleashes a record 28 actively managed thematic ETFs, offering hyper-niche strategies at a disruptive price point for investors.

As it prepares to go public, autonomous defense firm Powerus adds fmr. Naval Special Warfare Commander Jamie Sands to its board to close the tech gap.

With COO Nicole Miller now President, Nordis Technologies reshuffles leadership to accelerate its AI-driven customer communications and payments platform.

A major expansion of the Water-AI Nexus brings tech giants and water experts together to solve a critical paradox: AI's water use vs. its potential.

With $22M in new funding, Vori is deploying an AI-powered operating system to help independent grocers fight back in a market dominated by tech giants.

Citadel’s former CTO Umesh Subramanian joins Motive Partners, a move underscoring AI's new frontier and private equity's growing tech dominance.

The entertainment giant reported higher Q3 net income despite storms and weak consumer sentiment, leaning on AI-driven efficiencies and strategic acquisitions.

The architect of HUMIRA's launch and Horizon's $28B sale is now shaping the next wave of drug companies from within private equity. What does it mean?

Elisa taps Vecima's All-PON technology to deliver 10G fiber services in Estonia, signaling a new era of connectivity for the digitally advanced nation.

Telecom giant Liberty Global invests in AI security firm XBOW, signaling a strategic shift to proactive, machine-speed defense against evolving cyber threats.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

Backed by private equity, DTK unveils a bold strategy targeting AI, glass substrates, and a 2028 IPO, aiming for a high-tech transformation.

As the specialty chemicals market booms, firms are betting on AI. Uncountable's latest deals show how data is becoming the industry's most vital catalyst.

As EyePoint's losses widen to fund its lead drug, DURAVYU, the company is on the cusp of pivotal trial results that could redefine retinal disease treatment.

With the hire of a Project Maven expert, the investment firm signals a major push to embed advanced AI into its middle-market defense companies.

As claim denials surge, VisiQuate's new AI platform promises to help hospitals predict and prevent revenue loss from confusing and complex payer policies.